- Knee Osteoarthritis
- Hip Osteoarthritis
- Shoulder Osteoarthritis
- Ankle Osteoarthritis
Hyaluronic Acid Viscosupplementation Market Size was valued at USD 3.14 billion in 2022 and is poised to grow at a CAGR of 8.1% from 2023-29. The key drivers are considered to be an increase in the number of people with osteoarthritis, the obese population due to the change in lifestyle, and the geriatric population contributing towards the growth of the global hyaluronic acid viscosupplementation market. The key challenges include lack of safety and efficacy and complex regulatory process because reimbursement policies of different countries are independent of each other there are a considerable number of pipeline drugs waiting for approval. Demand for non-surgical methods and high lifestyle-related diseases open up a huge market for the global market. Osteoarthritis is treated using a method called viscosupplementation. Because there is no treatment for arthritis, viscosupplementation is used to help the condition better. It is a viscous fluid called hyaluronate that is injected into the body to help support the synovial fluid's lubricating characteristics. As a result, it lessens the discomfort associated with osteoarthritis of the knee, improves mobility, and provides a more comfortable level of exercise. This is only utilized when other treatment options have been exhausted and failed to help with the management. The market is fueled by major factors such as an increase in the number of individuals suffering from osteoarthritis, which is expected to move the industry forward. The market is expected to grow throughout the projected period as people become more aware of the new treatments available for osteoarthritis management.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
It is noticed that the global hyaluronic acid viscosupplementation market is influenced mainly by the number of osteoarthritis patients which is the key factor causing the hyaluronic acid viscosupplementation market to grow. According to WHO (World Health Organization) 18% women and 9.6% men over the age of 60 years suffer from Osteoarthritis among this 25% cannot participate in the daily activities and 80% have very contracted resisted movements. Key factors contributing this is unhealthy lifestyle due to the overweight the joint get weakened and effect the movements other one is old age group the bones and join get weakened which hinder the mobility hence contributing the high growth in global hyaluronic acid viscosupplementation market.
North America contributed major revenue followed by Europe and Asia Pacific. In 2019, North America region accounted huge growth rate and is anticipated to grow with a forecast year. For instance, to population reference bureau the population of America aged 65 or more who’s suffering from hyaluronic acid viscosupplementation related disease are increased from 46 million to 98 million. 80% of the treatment cost is provided by government hence they are considered as leading players in global market. Europe have a stable market value because of budget constraint better example for this is five injection market in Germany which overall contribute to global hyaluronic acid viscosupplementation market.
Latin America
Europe
Asia Pacific
Middle East
North America
The Hyaluronic Acid Viscosupplementation Market size was valued at USD 3.14 billion in 2022
Anika Therapeutics, Inc. Ferring B.V. Zimmer Biomet Fidia Pharma USA Inc, LG Chem Sanofi SEIKAGAKU CORPORATION
North America is the fastest-growing region hyaluronic acid viscosupplementation market
| 1.Executive Summary |
| 2.Global Hyaluronic Acid Viscosupplementation Market Introduction |
| 2.1.Global Hyaluronic Acid Viscosupplementation Market - Taxonomy |
| 2.2.Global Hyaluronic Acid Viscosupplementation Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Treatment Type |
| 2.2.3.Dosage Form |
| 2.2.4.End-User |
| 2.2.5.Region |
| 3.Global Hyaluronic Acid Viscosupplementation Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Hyaluronic Acid Viscosupplementation Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Hyaluronic Acid Viscosupplementation Market By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Knee Osteoarthritis |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Hip Osteoarthritis |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Shoulder Osteoarthritis |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Ankle Osteoarthritis |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Hyaluronic Acid Viscosupplementation Market By Treatment Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Single-Injection |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Two-Injection |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Three-Injection |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Five-Injection |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Hyaluronic Acid Viscosupplementation Market By Dosage Form, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Solution |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Gel |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8.Global Hyaluronic Acid Viscosupplementation Market By End-User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Specialty Clinics |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Ambulatory Surgical Centers |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Hyaluronic Acid Viscosupplementation Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Hyaluronic Acid Viscosupplementation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Knee Osteoarthritis |
| 10.1.2.Hip Osteoarthritis |
| 10.1.3.Shoulder Osteoarthritis |
| 10.1.4.Ankle Osteoarthritis |
| 10.2. Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Single-Injection |
| 10.2.2.Two-Injection |
| 10.2.3.Three-Injection |
| 10.2.4.Five-Injection |
| 10.3. Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Solution |
| 10.3.2.Gel |
| 10.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals |
| 10.4.2.Specialty Clinics |
| 10.4.3.Ambulatory Surgical Centers |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Hyaluronic Acid Viscosupplementation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Knee Osteoarthritis |
| 11.1.2.Hip Osteoarthritis |
| 11.1.3.Shoulder Osteoarthritis |
| 11.1.4.Ankle Osteoarthritis |
| 11.2. Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Single-Injection |
| 11.2.2.Two-Injection |
| 11.2.3.Three-Injection |
| 11.2.4.Five-Injection |
| 11.3. Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Solution |
| 11.3.2.Gel |
| 11.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals |
| 11.4.2.Specialty Clinics |
| 11.4.3.Ambulatory Surgical Centers |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Hyaluronic Acid Viscosupplementation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Knee Osteoarthritis |
| 12.1.2.Hip Osteoarthritis |
| 12.1.3.Shoulder Osteoarthritis |
| 12.1.4.Ankle Osteoarthritis |
| 12.2. Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Single-Injection |
| 12.2.2.Two-Injection |
| 12.2.3.Three-Injection |
| 12.2.4.Five-Injection |
| 12.3. Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Solution |
| 12.3.2.Gel |
| 12.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals |
| 12.4.2.Specialty Clinics |
| 12.4.3.Ambulatory Surgical Centers |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Hyaluronic Acid Viscosupplementation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Knee Osteoarthritis |
| 13.1.2.Hip Osteoarthritis |
| 13.1.3.Shoulder Osteoarthritis |
| 13.1.4.Ankle Osteoarthritis |
| 13.2. Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Single-Injection |
| 13.2.2.Two-Injection |
| 13.2.3.Three-Injection |
| 13.2.4.Five-Injection |
| 13.3. Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Solution |
| 13.3.2.Gel |
| 13.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals |
| 13.4.2.Specialty Clinics |
| 13.4.3.Ambulatory Surgical Centers |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Hyaluronic Acid Viscosupplementation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Knee Osteoarthritis |
| 14.1.2.Hip Osteoarthritis |
| 14.1.3.Shoulder Osteoarthritis |
| 14.1.4.Ankle Osteoarthritis |
| 14.2. Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Single-Injection |
| 14.2.2.Two-Injection |
| 14.2.3.Three-Injection |
| 14.2.4.Five-Injection |
| 14.3. Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Solution |
| 14.3.2.Gel |
| 14.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals |
| 14.4.2.Specialty Clinics |
| 14.4.3.Ambulatory Surgical Centers |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Anika Therapeutics Inc |
| 15.2.2.Ferring B.V |
| 15.2.3.Zimmer Biomet |
| 15.2.4.Fidia Pharma USA Inc |
| 15.2.5.LG Chem |
| 15.2.6.Sanofi |
| 15.2.7.SEIKAGAKU CORPORATION |
| 15.2.8.Lifecore Biomedical |
| 15.2.9.Hoffmann-La Roche Ltd |
| 15.2.10.Bausch Health |
| 15.2.11.Smith & Nephew |
| 15.2.12.Alcon Vision LLC |
| 15.2.13.ALLERGAN |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |